Is pharma investing in the right digital solutions?

Digital transformation has gathered pace in pharma and we have all been witnessing the acceleration. New technologies have been adopted to ensure HCP engagement is maintained but keeping up the understanding of innovative and emerging solutions and investing in the right technologies may prove challenging.

A report authored by Reuters Events Pharma and Elsevier discusses that spending on digital is likely to take a larger proportion of promotional budgets moving forward. It is anticipated that budgets for digital promotion are likely to increase by over 23% in the next three years, while print promotion will drop by 40%.

It is clear that there is an appetite for changing the promotional landscape, but spending the additional digital budget wisely is critical to the return on investment. Tangent90’s Trustrack solution comprehensively manages the distribution of published digital scientific content, aligning well with the ‘science first’ approach adopted by many pharma companies for their HCP digital engagement approach. As one of the first-ever Veeva Silver Certified Technology Partners, we have developed a solution which enables pharma to share digital copyright content direct with HCPs – managing the publishers’ intellectual property at source. The distribution and tracking of peer-reviewed scientific publications, as well as related published digital content such as quick-take videos, help drive meaningful engagement with HCPs and works within pharma’s existing ecosystem and using their existing channels. It provides a complete 360-degree view of what content has been shared and how it has been used, which is fed directly back to pharma’s CRM. This process provides actionable insights, as well as complete control of the volume of content shared to avoid overwhelming the HCP.

To find out more about how Tangent90 can support you to manage your digital scientific content distribution, please contact us at [email protected].

Related news

Medical journal

Why relevance and impact are so important for HCPs

Making an impact attracts attention. Doesn’t it? Well, yes but only if the subject of the impact is relevant to the person being impacted. For it to resonate, it needs to be timed to perfection and the subject be of specific relevance to the recipient.

T90 Perspective

The omnichannel revolution

Omnichannel is more than just a buzzword. It is influencing the customer journey in pharma. Adding published scientific content to your omnichannel strategy can help add greater value for HCPs. Read the T90 perspective>>

Personalised email

Making it personal

What would make you more likely to respond? A dry, generic, mass-produced approach or one that addresses you personally and provides specific information on a topic of interest in an easy-to-digest format via a channel of your choice? We know what we’d prefer!

Scroll to Top

Book A Demo

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.